Literature DB >> 34080150

The NDUFS4 Knockout Mouse: A Dual Threat Model of Childhood Mitochondrial Disease and Normative Aging.

Anthony S Grillo1, Alessandro Bitto1, Matt Kaeberlein2.   

Abstract

Mice missing the Complex I subunit NADH:Ubiquinone Oxidoreductase Fe-S Protein 4 (NDUFS4) of the electron transport chain are a leading model of the severe mitochondrial disease Leigh syndrome. These mice have enabled a better understanding of mitochondrial dysfunction in human disease, as well as in the discovery of interventions that can potentially suppress mitochondrial disease manifestations. In addition, increasing evidence suggests significant overlap between interventions that increase survival in NDUFS4 knockout mice and that extend life span during normative aging. This chapter discusses the practical aspects of handling and studying these mice, which can be challenging due to their severe disease phenotype. Common procedures such as breeding, genotyping, weaning, or treating these transgenic mice are also discussed.

Entities:  

Keywords:  Aging; Complex I; Electron transport chain; Hypoxia; Leigh syndrome; Mitochondrial disease; Mitochondrial dysfunction; NAD; NDUFS4; Rapamycin; mTOR

Year:  2021        PMID: 34080150     DOI: 10.1007/978-1-0716-1270-5_10

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  12 in total

Review 1.  Mitochondriopathies.

Authors:  J Finsterer
Journal:  Eur J Neurol       Date:  2004-03       Impact factor: 6.089

2.  mTOR inhibition alleviates mitochondrial disease in a mouse model of Leigh syndrome.

Authors:  Simon C Johnson; Melana E Yanos; Ernst-Bernhard Kayser; Albert Quintana; Maya Sangesland; Anthony Castanza; Lauren Uhde; Jessica Hui; Valerie Z Wall; Arni Gagnidze; Kelly Oh; Brian M Wasko; Fresnida J Ramos; Richard D Palmiter; Peter S Rabinovitch; Philip G Morgan; Margaret M Sedensky; Matt Kaeberlein
Journal:  Science       Date:  2013-11-14       Impact factor: 47.728

Review 3.  Cellular and animal models for mitochondrial complex I deficiency: a focus on the NDUFS4 subunit.

Authors:  Megan E Breuer; Peter H G M Willems; Jan A M Smeitink; Werner J H Koopman; Marco Nooteboom
Journal:  IUBMB Life       Date:  2013-02-03       Impact factor: 3.885

4.  Hypoxia as a therapy for mitochondrial disease.

Authors:  Isha H Jain; Luca Zazzeron; Rahul Goli; Kristen Alexa; Stephanie Schatzman-Bone; Harveen Dhillon; Olga Goldberger; Jun Peng; Ophir Shalem; Neville E Sanjana; Feng Zhang; Wolfram Goessling; Warren M Zapol; Vamsi K Mootha
Journal:  Science       Date:  2016-02-25       Impact factor: 47.728

Review 5.  The hallmarks of aging.

Authors:  Carlos López-Otín; Maria A Blasco; Linda Partridge; Manuel Serrano; Guido Kroemer
Journal:  Cell       Date:  2013-06-06       Impact factor: 41.582

6.  Hepatic S6K1 Partially Regulates Lifespan of Mice with Mitochondrial Complex I Deficiency.

Authors:  Takashi K Ito; Chenhao Lu; Jacob Khan; Quy Nguyen; Heather Z Huang; Dayae Kim; James Phillips; Jo Tan; Yenna Lee; Tuyet Nguyen; Samy Khessib; Natalie Lim; Surapat Mekvanich; Joshua Oh; Victor V Pineda; Weirong Wang; Alessandro Bitto; Jonathan Y An; John F Morton; Mitsutoshi Setou; Warren C Ladiges; Matt Kaeberlein
Journal:  Front Genet       Date:  2017-09-01       Impact factor: 4.599

7.  Targeting NAD+ Metabolism as Interventions for Mitochondrial Disease.

Authors:  Chi Fung Lee; Arianne Caudal; Lauren Abell; G A Nagana Gowda; Rong Tian
Journal:  Sci Rep       Date:  2019-02-28       Impact factor: 4.379

8.  Mice with mitochondrial complex I deficiency develop a fatal encephalomyopathy.

Authors:  Shane E Kruse; William C Watt; David J Marcinek; Raj P Kapur; Kenneth A Schenkman; Richard D Palmiter
Journal:  Cell Metab       Date:  2008-04       Impact factor: 27.287

9.  Dose-dependent effects of mTOR inhibition on weight and mitochondrial disease in mice.

Authors:  Simon C Johnson; Melana E Yanos; Alessandro Bitto; Anthony Castanza; Arni Gagnidze; Brenda Gonzalez; Kanav Gupta; Jessica Hui; Conner Jarvie; Brittany M Johnson; Nicolas Letexier; Lanny McCanta; Maya Sangesland; Oliver Tamis; Lauren Uhde; Alex Van Den Ende; Peter S Rabinovitch; Yousin Suh; Matt Kaeberlein
Journal:  Front Genet       Date:  2015-07-22       Impact factor: 4.599

10.  Exploring mTOR inhibition as treatment for mitochondrial disease.

Authors:  Abigail Sage-Schwaede; Kristin Engelstad; Rachel Salazar; Angela Curcio; Alexander Khandji; James H Garvin; Darryl C De Vivo
Journal:  Ann Clin Transl Neurol       Date:  2019-08-06       Impact factor: 4.511

View more
  1 in total

Review 1.  Mitochondrial protein dysfunction in pathogenesis of neurological diseases.

Authors:  Liang Wang; Ziyun Yang; Xiumei He; Shiming Pu; Cheng Yang; Qiong Wu; Zuping Zhou; Xiaobo Cen; Hongxia Zhao
Journal:  Front Mol Neurosci       Date:  2022-09-07       Impact factor: 6.261

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.